Target intelligence / Profile preview

Reticular activating system (RAS (occasionally ARAS for ascending reticular activating system))

Target
RAS (occasionally ARAS for ascending reticular activating system)
Molecular classification
Other (complex brainstem network, not a single molecule or receptor)
01

Overview

The Reticular activating system is a functional network within the brainstem composed of interconnected nuclei, including the locus coeruleus, raphe nuclei, tuberomammillary nucleus, and pedunculopontine tegmentum, which regulate arousal, wakefulness, attention, and filtering of sensory information to the cortex. These nuclei use diverse neurotransmitters (norepinephrine, serotonin, histamine, acetylcholine) to modulate global brain states and help determine what sensory input reaches conscious awareness, contributing to sleep-wake cycles, attention, emotional responses, and learning and habituation. Dysfunction of the system can result in coma, narcolepsy, or attentional deficits. The RAS is not a molecular target or receptor itself, but drugs modulate its function via neurotransmitter pathways within its component nuclei.

Other names
ARAS (Ascending reticular activating system)reticular formation (when referring more broadly)
02

Mechanism of action

Alter neurotransmitter release or receptor activation within nuclei of the RAS (e.g. locus coeruleus - norepinephrine, raphe nuclei - serotonin, tuberomammillary nucleus - histamine, pedunculopontine tegmentum - acetylcholine); Modulate sleep-wake transitions and arousal states via effects on RAS circuitry

03

Biological functions

Arousal and wakefulnessConsciousnessAttentional filteringSensory information gatingSleep-wake transitionsMood and emotional modulationLearning and habituation
04

Disease associations

Coma and consciousness disorders (injury or dysfunction can cause coma or altered arousal)Narcolepsy and sleep disordersAttention deficit/hyperactivity disorder (suggested by role in attentional gating; not a direct molecular target)Other (brainstem injury-related syndromes, e.g., decerebrate/decorticate rigidity)
05

Safety considerations

Risk of coma or permanent loss of consciousness if RAS-related regions are damaged (stroke, trauma)Sedative or stimulant drugs can alter RAS function and cause dependence, cognitive impairment, or psychosis depending on dose and vulnerability
06

Interacting drugs

Stimulants (e.g., amphetamines affect arousal via neurotransmitter pathways in RAS nuclei; not directly targeting "RAS")

3 more in the full profile.

Beyond the preview

Go deeper on Reticular activating system (RAS (occasionally ARAS for ascending reticular activating system)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Reticular activating system (RAS (occasionally ARAS for ascending reticular activating system)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call